Article 11-5(Designation of promising biotechnologies) #
(1) Where necessary to designate promising biotechnologies under Article 11-2 (1) of the Act, the Minister of Science and ICT shall conduct demand surveys for other relevant central administrative agencies, local governments, enterprises, universities, research institutes, medical institutions, and biotechnology-related entities and organizations.
(2) The heads of relevant central administrative agencies, the heads of research and development institutes under subparagraph 3 of Article 2 of the National Research and Development Innovation Act, and the heads of medical institutions may request the Minister of Science and ICT to designate promising biotechnologies.
(3) A person who intends to request the designation of a promising biotechnology in accordance with paragraph (2) shall submit to the Minister of Science and ICT the following materials:
1. Scope and content of the technology for which the designation is requested;
2. Grounds for requesting the designation;
3. Materials related to Article 11-2 (2) 1 through 4 of the Act;
4. Opinions of experts from industry, academia, research circles, etc. related to the technology for which the designation is requested;
5. Other reference materials regarding the technology for which the designation is requested.
(4) The Minister of Science and ICT may provide support for the following matters within the budget for promising biotechnologies designated under Article 11-2 (1) of the Act:
1. Research and development of promising biotechnologies and follow-up research and development to promote commercialization of research and development outcomes;
2. Production of prototypes to verify the effectiveness of technological development;
3. Demonstration related to promising biotechnologies;
4. Obtainment of authorization, permission, approval, etc. under applicable statutes and regulations;
5. Establishment and development of public sector markets for promising biotechnology-related products and services;
6. Consultation, technology assessment, and technology transactions to promote the transfer and commercialization of promising biotechnologies;
7. Dissemination activities and public outreach to increase social acceptance of promising biotechnologies;
8. Other matters for which the Minister of Science and ICT determines support is necessary for the development and commercialization of promising biotechnologies.
(5) The head of a relevant central administrative agency, the head of a research and development institute defined in subparagraph 3 of Article 2 of the National Research and Development Innovation Act, and the head of a medical institution may request the Minister of Science and ICT to change or revoke the designation of a promising biotechnology under Article 11-2 (3) of the Act if they recognize that it is necessary to change or revoke the designation of the promising biotechnology already designated due to changes in the technological environment, such as the emergence of advanced technologies or the widespread use of promising technologies.
(6) A person who requests to change or revoke the designation of a promising biotechnology under paragraph (5) shall submit to the Minister of Science and ICT the following materials:
1. Scope and content of the promising biotechnology in question;
2. Grounds for requesting change or revocation of designation;
3. Other reference materials regarding the request for change or revocation of designation of the promising biotechnology.
(7) Upon receipt of a request under paragraph (2) or (5), the Minister of Science and ICT may designate a promising biotechnology or change or revoke the designation of the promising biotechnology after hearing opinions of relevant experts and reviewing the feasibility of the request, and after deliberation by the Council under Article 11-2 of the Act.
[This Article added on April 22, 2025]